This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sisson, G.
Right arrow Articles by Hoffman, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sisson, G.
Right arrow Articles by Hoffman, P. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2002, p. 2116-2123, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2116-2123.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Enzymes Associated with Reductive Activation and Action of Nitazoxanide, Nitrofurans, and Metronidazole in Helicobacter pylori

Gary Sisson,1 Avery Goodwin,1,2 Ausra Raudonikiene,1 Nicky J. Hughes,2 Asish K. Mukhopadhyay,3 Douglas E. Berg,3 and Paul S. Hoffman1,2,4*

Department of Microbiology and Immunology,1 Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Dalhousie University, HaliFax, Nova Scotia B3H 4H7,4 GlaxoSmithKline, Collegeville, Pennsylvania,2 Department of Molecular Microbiology and Department of Genetics, Washington University Medical School, St. Louis, Missouri3

Received 17 December 2001/ Returned for modification 27 February 2002/ Accepted 10 April 2002

Nitazoxanide (NTZ) is a redox-active nitrothiazolyl-salicylamide prodrug that kills Helicobacter pylori and also many anaerobic bacterial, protozoan, and helminthic species. Here we describe development and use of a spectrophotometric assay, based on nitroreduction of NTZ at 412 nm, to identify H. pylori enzymes responsible for its activation and mode of action. Three enzymes that reduce NTZ were identified: two related NADPH nitroreductases, which also mediate susceptibility to metronidazole (MTZ) (RdxA and FrxA), and pyruvate oxidoreductase (POR). Recombinant His-tagged RdxA, FrxA, and POR, overexpressed in nitroreductase-deficient Escherichia coli, each rapidly reduced NTZ, whereas only FrxA and to a lesser extent POR reduced nitrofuran substrates (furazolidone, nitrofurantoin, and nitrofurazone). POR exhibited no MTZ reductase activity either in extracts of H. pylori or following overexpression in E. coli; RdxA exhibited no nitrofuran reductase activity, and FrxA exhibited no MTZ reductase activity. Analysis of mutation to rifampin resistance (Rifr) indicated that NTZ was not mutagenic and that nitrofurans were only weakly mutagenic. Alkaline gel DNA electrophoresis indicated that none of these prodrugs caused DNA breakage. In contrast, MTZ caused DNA damage and was strongly mutagenic. We conclude that POR, an essential enzyme, is responsible for most or all of the bactericidal effects of NTZ against H. pylori. While loss-of-function mutations in rdxA and frxA produce a Mtzr phenotype, they do not contribute much to the innate susceptibility of H. pylori to NTZ or nitrofurans.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, Sir Charles Tupper Medical Bldg., Room 7P, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada. Phone: (902) 494-3889. Fax: (902) 494-5125. E-mail: phoffman{at}tupdean2.med.dal.ca.


Antimicrobial Agents and Chemotherapy, July 2002, p. 2116-2123, Vol. 46, No. 7
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.7.2116-2123.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Vets, E., Rossignol, J.-F., Jackson, A. S. (2009). Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin. Am J Health Syst Pharm 66: 838-842 [Abstract] [Full Text]  
  • LeBlanc, J. J., Brassinga, A. K. C., Ewann, F., Davidson, R. J., Hoffman, P. S. (2008). An Ortholog of OxyR in Legionella pneumophila Is Expressed Postexponentially and Negatively Regulates the Alkyl Hydroperoxide Reductase (ahpC2D) Operon. J. Bacteriol. 190: 3444-3455 [Abstract] [Full Text]  
  • Moir, D. T., Ming Di, , Opperman, T., Schweizer, H. P., Bowlin, T. L. (2007). A High-Throughput, Homogeneous, Bioluminescent Assay for Pseudomonas aeruginosa Gyrase Inhibitors and Other DNA-Damaging Agents. J Biomol Screen 12: 855-864 [Abstract]  
  • Smith, A. L., Erwin, A. L., Kline, T., Unrath, W. C. T., Nelson, K., Weber, A., Howald, W. N. (2007). Chloramphenicol Is a Substrate for a Novel Nitroreductase Pathway in Haemophilus influenzae. Antimicrob. Agents Chemother. 51: 2820-2829 [Abstract] [Full Text]  
  • St. Maurice, M., Cremades, N., Croxen, M. A., Sisson, G., Sancho, J., Hoffman, P. S. (2007). Flavodoxin:Quinone Reductase (FqrB): a Redox Partner of Pyruvate:Ferredoxin Oxidoreductase That Reversibly Couples Pyruvate Oxidation to NADPH Production in Helicobacter pylori and Campylobacter jejuni. J. Bacteriol. 189: 4764-4773 [Abstract] [Full Text]  
  • Muller, J., Wastling, J., Sanderson, S., Muller, N., Hemphill, A. (2007). A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides. Antimicrob. Agents Chemother. 51: 1979-1986 [Abstract] [Full Text]  
  • Hoffman, P. S., Sisson, G., Croxen, M. A., Welch, K., Harman, W. D., Cremades, N., Morash, M. G. (2007). Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori, Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 51: 868-876 [Abstract] [Full Text]  
  • Naguleswaran, A., Spicher, M., Vonlaufen, N., Ortega-Mora, L. M., Torgerson, P., Gottstein, B., Hemphill, A. (2006). In Vitro Metacestodicidal Activities of Genistein and Other Isoflavones against Echinococcus multilocularis and Echinococcus granulosus. Antimicrob. Agents Chemother. 50: 3770-3778 [Abstract] [Full Text]  
  • Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., Barry, C. E. III (2006). Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103: 431-436 [Abstract] [Full Text]  
  • Muller, J., Ruhle, G., Muller, N., Rossignol, J.-F., Hemphill, A. (2006). In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells. Antimicrob. Agents Chemother. 50: 162-170 [Abstract] [Full Text]  
  • Esposito, M., Stettler, R., Moores, S. L., Pidathala, C., Muller, N., Stachulski, A., Berry, N. G., Rossignol, J.-F., Hemphill, A. (2005). In Vitro Efficacies of Nitazoxanide and Other Thiazolides against Neospora caninum Tachyzoites Reveal Antiparasitic Activity Independent of the Nitro Group. Antimicrob. Agents Chemother. 49: 3715-3723 [Abstract] [Full Text]  
  • Race, P. R., Lovering, A. L., Green, R. M., Ossor, A., White, S. A., Searle, P. F., Wrighton, C. J., Hyde, E. I. (2005). Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone: REVERSED BINDING ORIENTATIONS IN DIFFERENT REDOX STATES OF THE ENZYME. J. Biol. Chem. 280: 13256-13264 [Abstract] [Full Text]  
  • Zaleski, P., Piekarowicz, A. (2004). Characterization of a dam mutant of Haemophilus influenzae Rd. Microbiology 150: 3773-3781 [Abstract] [Full Text]  
  • Gerrits, M. M, van der Wouden, E.-J., Bax, D. A, van Zwet, A. A, van Vliet, A. H., de Jong, A., Kusters, J. G, Thijs, J. C, Kuipers, E. J (2004). Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori. J Med Microbiol 53: 1123-1128 [Abstract] [Full Text]  
  • Walker, M., Rossignol, J. F., Torgerson, P., Hemphill, A. (2004). In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes. J Antimicrob Chemother 54: 609-616 [Abstract] [Full Text]  
  • Bailey, J. M, Erramouspe, J. (2004). Nitazoxanide Treatment for Giardiasis and Cryptosporidiosis in Children. The Annals of Pharmacotherapy 38: 634-640 [Abstract] [Full Text]  
  • Chisholm, S. A., Owen, R. J. (2004). Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol 53: 135-140 [Abstract] [Full Text]  
  • Guttner, Y., Windsor, H. M., Viiala, C. H., Dusci, L., Marshall, B. J. (2003). Nitazoxanide in Treatment of Helicobacter pylori: a Clinical and In Vitro Study. Antimicrob. Agents Chemother. 47: 3780-3783 [Abstract] [Full Text]  
  • (2003). Nitazoxanide. JWatch Infect. Diseases 2003: 11-11 [Full Text]  
  • Mukhopadhyay, A. K., Jeong, J.-Y., Dailidiene, D., Hoffman, P. S., Berg, D. E. (2003). The fdxA Ferredoxin Gene Can Down-Regulate frxA Nitroreductase Gene Expression and Is Essential in Many Strains of Helicobacter pylori. J. Bacteriol. 185: 2927-2935 [Abstract] [Full Text]  
  • Stettler, M., Fink, R., Walker, M., Gottstein, B., Geary, T. G., Rossignol, J. F., Hemphill, A. (2003). In Vitro Parasiticidal Effect of Nitazoxanide against Echinococcus multilocularis Metacestodes. Antimicrob. Agents Chemother. 47: 467-474 [Abstract] [Full Text]  
  • Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., Berg, D. E. (2002). Emergence of Tetracycline Resistance in Helicobacter pylori: Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci. Antimicrob. Agents Chemother. 46: 3940-3946 [Abstract] [Full Text]